Altered expression of metallothionein-i and-ii and their receptor megalin in inherited photoreceptor degeneration

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 9, 2010, Pages 4809-4820

  Wunderlich, Kirsten A ^a,b,c   Leveillard, Thierry ^d   Penkowa, Milena ^e   Zrenner, Eberhart ^c   Perez, Maria Thereza ^a,f  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d INSERM   (France)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; ISOLECTIN B4; MEGALIN; METALLOTHIONEIN I; METALLOTHIONEIN II; AVIDIN; BIOLOGICAL MARKER; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; METALLOTHIONEIN; METALLOTHIONEIN 2 PROTEIN, RAT; NERVE PROTEIN; PDE6B PROTEIN, MOUSE; PHOSPHODIESTERASE VI;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CROSSOVER PROCEDURE; GENE EXPRESSION; GENE INDUCTION; GLIA CELL; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; MUELLER CELL; NERVE FIBER; NICK END LABELING; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; RETINA DEGENERATION; RETINITIS PIGMENTOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ASTROCYTE; C3H MOUSE; DISEASE MODEL; DNA MICROARRAY; GENETICS; METABOLISM; MICROGLIA; MOUSE MUTANT; PATHOLOGY; PHOTORECEPTOR CELL; RETINA GANGLION CELL; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; AVIDIN; BIOLOGICAL MARKERS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 6; DISEASE MODELS, ANIMAL; IN SITU NICK-END LABELING; LDL-RECEPTOR RELATED PROTEIN 2; METALLOTHIONEIN; MICE; MICE, INBRED C3H; MICE, MUTANT STRAINS; MICROGLIA; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOTORECEPTOR CELLS, VERTEBRATE; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; RETINITIS PIGMENTOSA;

EID: 77957338177     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5073     Document Type: Article

References (94)

1. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006; 368: 1795-1809.
2. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006; 1: 40.
3. LaVail MM, Yasumura D, Matthes MT, et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci. 1998; 39: 592-602.
4. Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A. 2006; 103: 3896-3901.
5. Ahuja P, Caffé AR, Holmqvist I, et al. Lens epithelium-derived growth factor (LEDGF) delays photoreceptor degeneration in explants of rd/rd mouse retina. Neuroreport. 2001; 12: 2951-2955.
6. Delyfer MN, Simonutti M, Neveux N, Léveillard T, Sahel JA. Does GDNF exert its neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST? Mol Vis. 2005; 11: 677-687.
7. Azadi S, Johnson LE, Paquet-Durand F, et al. CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina. Brain Res. 2007; 1129: 116-129.
8. Palmiter RD. The elusive function of metallothioneins. Proc Natl Acad Sci U S A. 1998; 95: 8428-8430.
9. Hidalgo J, Aschner M, Zatta P, Vasák M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull. 2001; 55: 133-145.
10. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci. 2002; 59: 627-647.
11. Haq F, Mahoney M, Koropatnick J. Signaling events for metallothionein induction. Mutat Res. 2003; 533: 211-226.
12. Penkowa M. Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS Lett J. 2006; 273: 1857-1870.
13. Nielsen AE, Bohr A, Penkowa M. The balance between life and death of cells: roles of metallothioneins. Biomark Insights. 2007; 1: 99-111.
14. Hidalgo J, Chung R, Penkowa M, Vasák M. Structure and functions of vertebrate metallothioneins. In: Sigel A, Sigel H, Sigel RKO, eds. Metal Ions in Life Sciences: Metallothioneins and Related Chelators. Vol.5. Cambridge, UK: The Royal Society of Chemistry. 2009: 279-317.
15. Pedersen MØ, Larsen A, Stoltenberg M, Penkowa M. Cell death in the injured brain: roles of metallothioneins. Prog Histochem Cytochem. 2009; 44: 1-27.
16. Maret W, Vallee BL. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci U S A. 1998; 95: 3478-3482.
17. Sato M, Kondoh M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med. 2002; 196: 9-22.
18. Stankovic RK, Chung RS, Penkowa M. Metallothioneins I and II: neuroprotective significance during CNS pathology. Int J Biochem Cell Biol. 2007; 39: 484-489.
19. Pedersen MØ, Jensen R, Pedersen DS, et al. Metallothionein-I+II in neuroprotection. Biofactors. 2009; 35: 315-325.
20. Nishimura H, Nishimura N, Kobayashi S, Tohyama C. Immunohistochemical localization of metallothionein in the eye of rats. Histochemistry. 1991; 95: 535-539.
21. Oliver PD, Tate DJ, Newsome DA. Metallothionein in human retinal pigment epithelial cells: expression, induction and zinc uptake. Curr Eye Res. 1992; 11: 183-188.
22. Tate DJ, Newsome DA, Oliver PD. Metallothionein shows an agerelated decrease in human macular retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1993; 34: 2348-2351.
23. Tate DJ, Miceli MV, Newsome DA, Alcock NW, Oliver PD. Influence of zinc on selected cellular functions of cultured human retinal pigment epithelium. Curr Eye Res. 1995; 14: 897-903.
24. Chen W, Hunt DM, Lu H, Hunt RC. Expression of antioxidant protective proteins in the rat retina during prenatal and postnatal development. Invest Ophthalmol Vis Sci. 1999; 40: 744-751.
25. Tate DJ, Miceli MV, Newsome DA. Expression of metallothionein isoforms in human chorioretinal complex. Curr Eye Res. 2002; 24: 12-25.
26. Suemori S, Shimazawa M, Kawase K, et al. Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. Invest Ophthalmol Vis Sci. 2006; 47: 3975-3982.
27. Chen L, Wu W, Dentchev T, Wong R, Dunaief JL. Increased metallothionein in light damaged mouse retinas. Exp Eye Res. 2004; 79: 287-293.
28. Vázquez-Chona F, Song BK, Geisert EE. Temporal changes in gene expression after injury in the rat retina. Invest Ophthalmol Vis Sci. 2004; 45: 2737-2746.
29. Thiersch M, Raffelsberger W, Frigg R, et al. Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection. BMC Genomics. 2008; 9: 73.
30. Nicolas MG, Fujiki K, Murayama K, et al. Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. Exp Eye Res. 1996; 62: 399-408.
31. Lu H, Hunt DM, Ganti R, et al. Metallothionein protects retinal pigment epithelial cells against apoptosis and oxidative stress. Exp Eye Res. 2002; 74: 83-92.
32. Wu Z, Rogers B, Kachi S, Hackett SF, Sick A, Campochiaro PA. Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. J Cell Physiol. 2006; 209: 996-1005.
33. Fitzgerald M, Nairn P, Bartlett CA, Chung RS, West AK, Beazley LD. Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp Brain Res. 2007; 183: 171-180.
34. Chung RS, Penkowa M, Dittmann J, et al. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem. 2008; 283: 15349-15358.
35. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol. 2002; 3: 256-266.
36. May P, Herz J, Bock HH. Molecular mechanisms of lipoprotein receptor signalling. Cell Mol Life Sci. 2005; 62: 2325-2338.
37. Ambjørn M, Asmussen JW, Lindstam M, et al. Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J Neurochem. 2008; 104: 21-37.
38. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature. 1990; 347: 677-680.
39. Sanyal S, Jansen HG. Absence of receptor outer segments in the retina of rds mutant mice. Neurosci Lett. 1981; 21: 23-26.
40. D'Cruz PM, Yasumura D, Weir J, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000; 9: 645-651.
41. Viczian A, Sanyal S, Toffenetti J, Chader GJ, Farber DB. Photoreceptor-specific mRNAs in mice carrying different allelic combinations at the rd and rds loci. Exp Eye Res. 1992; 54: 853-860.
42. Chirgwin J, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18: 5294-5299.
43. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996; 14: 1675-1680.
44. Wilson CL, Miller CJ. Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics. 2005; 21: 3683-3685.
45. Raffelsberger W, Krause Y, Moulinier L, et al. RReportGenerator: automatic reports from routine statistical analysis using R. Bioinformatics. 2008; 24: 276-278.
46. Kalathur RK, Gagniere N, Bertommier G, et al. RETINOBASE: a web database, data mining and analysis platform for gene expression data on retina. BMC Genomics. 2008; 9: 208.
47. Thiersch M, Lange C, Joly S, et al. Retinal neuroprotection by hypoxic preconditioning is independent of hypoxia-inducible factor-1 alpha expression in photoreceptors. Eur J Neurosci. 2009; 29: 2291-2302.
48. Dohi Y, Shimaoka H, Ikeuchi M, Ohgushi H, Yonemasu K, Minami T. Role of metallothionein isoforms in bone formation processes in rat marrow mesenchymal stem cells in culture. Biol Trace Elem Res. 2005; 104: 57-70.
49. Struthers L, Patel R, Clark J, Thomas S. Direct detection of 8--oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal Biochem. 1998; 255: 20-31.
50. Sanz MM, Johnson LE, Ahuja S, Ekström PA, Romero J, van Veen T. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neuroscience. 2007; 145: 1120-1129.
51. Söderberg O, Leuchowius KJ, Gullberg M, et al. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods. 2008; 45: 227-232.
52. Palmiter RD, Cole TB, Quaife CJ, Findley SD. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A. 1996; 93: 14934-14939.
53. Wu SM, Qiao X, Noebels JL, Yang XL. Localization and modulatory actions of zinc in vertebrate retina. Vision Res. 1993; 33: 2611-2616.
54. Redenti S, Chappell RL. Neuroimaging of zinc released by depolarization of rat retinal cells. Vision Res. 2005; 45: 3520-3525.
55. Ugarte M, Osborne NN. The localization of free zinc varies in rat photoreceptors during light and dark adaptation. Exp Eye Res. 1999; 69: 459-461.
56. Hack I, Koulen P, Peichl L, Brandstätter JH. Development of glutamatergic synapses in the rat retina: the postnatal expression of ionotropic glutamate receptor subunits. Vis Neurosci. 2002; 19: 1-13.
57. Penkowa M, Nielsen H, Hidalgo J, Bernth N, Moos T. Distribution of metallothionein I _ II and vesicular zinc in the developing central nervous system: correlative study in the rat. J Comp Neurol. 1999; 41: 303-318.
58. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995; 15: 4738-4747.
59. Kaji T, Yamamoto C, Suzuki M, et al. Induction of metallothionein by thrombin in cultured vascular endothelial and smooth muscle cells. Biol Pharm Bull. 1995; 18: 1272-1274.
60. Carter-Dawson LD, LaVail MM, Sidman RL. Differential effect of the rd mutation on rods and cones in the mouse retina. Invest Ophthalmol Vis Sci. 1978; 17: 489-498.
61. Komeima K, Rogers BS, Lu L, Campochiaro PA. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2006; 103: 11300-11305.
62. Bringmann A, Pannicke T, Grosche J, et al. Müller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006; 25: 397-424.
63. Wenzel A, Grimm C, Samardzija M, Remé C. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005; 24: 275-306.
64. Paquet-Durand F, Azadi S, Hauck SM, Ueffing M, van Veen T, Ekström P. Calpain is activated in degenerating photoreceptors in the rd1 mouse. J Neurochem. 2006; 96: 802-814.
65. Sanges D, Comitato A, Tammaro R, Marigo V. Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors. Proc Natl Acad Sci U S A. 2006; 103: 17366-17371.
66. Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med. 1999; 5: 1183-1187.
67. Farjo R, Skaggs JS, Nagel BA, et al. Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors. J Cell Biol. 2006; 173: 59-68.
68. Agarwal N, Nir I, Papermaster DS. Loss of diurnal arrestin gene expression in rds mutant mouse retinas. Exp Eye Res. 1994; 58: 1-8.
69. Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 1993; 11: 595-605.
70. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A. 1994; 91: 974-978.
71. Lewis GP, Fisher SK. Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol. 2003; 230: 263-290.
72. Zhang Y, Rauch U, Perez MT. Accumulation of neurocan, a brain chondroitin sulfate proteoglycan, in association with the retinal vasculature in RCS rats. Invest Ophthalmol Vis Sci. 2003; 44: 1252-1261.
73. Felmy F, Pannicke T, Richt JA, Reichenbach A, Guenther E. Electrophysiological properties of rat retinal Müller (glial) cells in postnatally developing and in pathologically altered retinae. Glia. 2001; 34: 190-199.
74. Iandiev I, Biedermann B, Bringmann A, Reichel MB, Reichenbach A, Pannicke T. Atypical gliosis in Müller cells of the slowly degenerating rds mutant mouse retina. Exp Eye Res. 2006; 82: 449-457.
75. Fletcher EL, Kalloniatis M. Neurochemical architecture of the normal and degenerating rat retina. J Comp Neurol. 1996; 376: 343-360.
76. Delyfer MN, Forster V, Neveux N, Picaud S, Léveillard T, Sahel JA. Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina. Mol Vis. 2005; 11: 688-696.
77. Redenti S, Ripps H, Chappell RL. Zinc release at the synaptic terminals of rod photoreceptors. Exp Eye Res. 2007; 85: 580-584.
78. Chappell RL, Anastassov I, Lugo P, Ripps H. Zinc-mediated feedback at the synaptic terminals of vertebrate photoreceptors. Exp Eye Res. 2008; 87: 394-397.
79. Redenti S, Chappell RL. Localization of zinc transporter-3 (ZnT-3) in mouse retina. Vision Res. 2004; 44: 3317-3321.
80. Wang X, Wang ZY, Gao HL, Danscher G, Huang L. Localization of ZnT7 and zinc ions in mouse retina: immunohistochemistry and selenium autometallography. Brain Res Bull. 2006; 71: 91-96.
81. Redenti S, Chappell RL. Müller cell zinc transporter-3 labeling suggests a role in outer retina zinc homeostasis. Mol Med. 2007; 13: 376-379.
82. Sergeant C, Gouget B, Llabador Y, et al. Iron and other elements (Cu, Zn, Ca) contents in retina of rats during development and hereditary retinal degeneration. Nucl Instr Methods Phys Res B. 2001; 181: 533-538.
83. Yefimova MG, Jeanny JC, Keller N, et al. Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci. 2002; 43: 537-545.
84. Verroust PJ, Christensen EI. Megalin and cubilin: the story of two multipurpose receptors unfolds. Nephrol Dial Transplant. 2002; 17: 1867-1871.
85. Bösl MR, Stein V, Hübner C, et al. Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption. EMBO J. 2001; 20: 1289-1299.
86. Kornak U, Kasper D, Bösl MR, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001; 104: 205-215.
87. Assémat E, Châtelet F, Chandellier J, et al. Overlapping expression patterns of the multiligand endocytic receptors cubilin and megalin in the CNS, sensory organs and developing epithelia of the rodent embryo. Gene Expr Patterns. 2005; 6: 69-78.
88. Christensen EI, Devuyst O, Dom G, et al. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci U S A. 2003; 100: 8472-8477.
89. Nachman-Clewner M, Giblin FJ, Dorey CK, et al. Selective degeneration of central photoreceptors after hyperbaric oxygen in normal and metallothionein-knockout mice. Invest Ophthalmol Vis Sci. 2008; 49: 3207-3215.
90. Samardzija M, Wenzel A, Aufenberg S, Thiersch T, Remé C, Grimm C. Differential role of Jak-STAT signaling in retinal degenerations. FASEB J. 2006; 20: 2411-2413.
91. Lee DK, Carrasco J, Hidalgo J, Andrews GK. Identification of a signal transducer and activator of transcription (STAT) binding site in the mouse metallothionein-I promoter involved in interleukin-6-induced gene expression. Biochem J. 1999; 337: 59-65.
92. Penkowa M, Giralt M, Lago N, et al. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol. 2003; 181: 130-148.
93. Holtkamp GM, Kijlstra A, Peek R, de Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001; 20: 29-48.
94. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007; 81: 1345-1351.